Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lexicon Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant has given written informed consent to participate in the study in accordance with local regulations
Adult male and female participants ≥18 years of age at the time of screening
Postherpetic neuralgia (PHN) pain that is present for ≥3 months after healing of herpes zoster skin rash affecting a single dermatome (Participants with more than 1 involved dermatome may also be included, provided the affected dermatomes are contiguous)
Moderate to severe pain as confirmed by average pain score using scores recorded in the pain diary in the 14 days prior to randomization
You may not be if
Presence of other painful conditions that may confound assessment or self-evaluation of PHN
History of major depressive episode, active, significant psychiatric disorders
History of clinically significant drug or alcohol use disorder
PHN affecting the face
Use of opioid medications for management of PHN within the 2 months prior to Screening Visit
Use of Non-steroidal anti-inflammatory drugs (NSAIDs) for the specific treatment of PHN pain
